Contracts

Reveo and the University of Washington to Develop Rapid DNA Sequencer Based on Novel Nano-Scale Phenomena.

BOSTON, MA (May 8, 2006) - Reveo, Inc. announces at NanoTech 2006 that it has teamed with the University of Washington to develop a breakthrough invention for rapid sequencing of DNA using novel nano-scale electronic and photonic effects that allow for bypassing many biochemical steps necessary in conventional DNA sequencing methods. The team will demonstrate proof of concept. The ultimate goal of this effort is to produce affordable and easy-to-use commercial products.

Army Phase II Project titled “Compact Alkaline Fuel Cell System” granted on 11/2/05.

ELMSFORD, NY (November 2, 2005) - Reveo has been awarded an Army Phase II SBIR Project entitled “Compact Alkaline Fuel Cell System” granted on 11/2/05, following the successful completion of Phase I. The mission of this project is to develop a very high-energy density, light weight power source for communications and other advanced electronic devices, which is currently met with primary Li/SO2 (e.g. BA-55901) and secondary lithium ion batteries.

Army Phase II Project titled “Novel Oxygen Pump for High Altitude Air Breathing Engines” granted on 8/9/05.

ELMSFORD, NY (August 9, 2005) - Reveo has been awarded an Army Phase II SBIR Project entitled “Novel Oxygen Pump for High Altitude Air Breathing Engines” granted on 8/9/05, following the successful Phase I. The mission of this project is to develop an oxygen enrichment pump to aid in the efficiency of airplane engines when they reach extremely high altitudes, harnessing the electrochemistry expertise of Reveo and its subsidiary eVionyx.

Reveo's Subsidiary eVionyx wins 3 SBIR contracts from Department of Defense.

HAWTHORNE, NY (June 30, 2004) - Reveo's subsidiary, eVionyx, has been awarded 3 separate SBIR contracts from the Department of Defense for work on various energy related projects. eVionyx has long been recognized as an innovator in developing new energy solutions, and these contracts re-affirm its technological capabilities in a wide variety of energy related subjects.

Reveo wins NASA SBIR contract to develop MFT for thermoelectric devices.

ELMSFORD, NY (February 20, 2004) - Reveo Laboratories has been awarded a contract from the NASA SBIR program to develop and modify Reveo's unique and proprietary MFT process for thermoelectric devices. This builds upon the success of Reveo's previous contract with DARPA in developing the MFT process. The MFT process is a broad enabling processing technology that can potentially affect a wide variety of industries, including microelectronics, nanotechnology, biotechnology, and thermoelectronics.

Syndicate content